Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

HBcAg (HBV) (18 - 27)

Name
HBcAg (HBV) (18 - 27)
Molecular structural formula
Purity
≥95%
Formula
C580H78N10O15
MW
1155.33
Sequence
Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val
Sequence Shortening
FLPSDFFPSV
InChIKey
WPDJAEURSVPNPM-HKFFZEPVSA-N
References
[1]. Kimura T, Rokuhara A, Matsumoto A, et al. (May 2003). "New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA". J. Clin. Microbiol. 41 (5): 1901–6. [2]. Cao T, Meuleman P, Desombere I, Sällberg M, Leroux-Roels G (December 2001). "In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model". J. Virol. 75 (23): 11449–56. [3]. Mandell,Douglas, and Bennett's Principles and Practice of Infectious Diseases. 7th ed. page 2062
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

HBcAg (core antigen) is a hepatitis B virus protein. It is an indicator of active viral replication, which means that a person infected with hepatitis B can easily spread the virus to another person. HBeAg is the extracellular form of hepatitis B surface antigen (HBcAg), both of which are markers of viral replication, and antibodies against these antigens are markers of decreased replication. The same DNA sequence yields a wide range of protein products. When "ORF Core" and "Pre C" are translated together, "HBeAg" is generated. While HBcAg is considered "granular" and "HBeAg" is considered "non-granular" or "secreted". HBeAg and HBcAg are derived from the same reading frame, HBeAg is secreted from cells and accumulates in serum as immunologically distinct soluble antigens. HBeAg is secreted and found in the patient's serum and can be used as a marker of active replication in chronic hepatitis. Although the function of HBeAg is not fully understood, it has been shown to downregulate Toll-like receptor 2 expression in hepatocytes and monocytes, resulting in a decrease in cytokine expression. HBeAg is dispensable for replication, and mutant viruses with defects in the pre-C region remain infectious and pathogenic.